MeSHing molecular sequences and clinical trials: A feasibility study

4Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The centralized and public availability of molecular sequence and clinical trial data presents an opportunity to identify potentially valuable linkages across the bench-to-bedside "T1" translational barrier. In this study, we sought to leverage keyword metadata (Medical Subject Heading [MeSH] descriptors) to infer relationships between molecular sequences and clinical trials, as indexed by GenBank and ClinicalTrials.gov. The results of this feasibility study found that approximately 30% of sequences in GenBank could be linked to trials and over 90% of trials in ClinicalTrials.gov could be linked to sequences through MeSH descriptors. In a cursory evaluation, we were able to consistently identify meaningful linkages between molecular sequences and clinical trials. Based on our findings, there may be promise in subsequent studies aiming to identify linkages across the T1 translational barrier using existing large repositories. © 2009 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Chen, E. S., & Sarkar, I. N. (2010). MeSHing molecular sequences and clinical trials: A feasibility study. Journal of Biomedical Informatics, 43(3), 442–450. https://doi.org/10.1016/j.jbi.2009.10.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free